Gene · 4633
Papers3,564
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,564
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antithrombin-III mitigates thrombin-mediated endothelial cell contraction and sickle red blood cell adhesion in microscale flow. | Br J Haematol | 2022 | 35822297 | PubTator, text mining | PubMed |
| Directed cell migration towards softer environments. | Nat Mater | 2022 | 35817964 | PubTator, text mining | PubMed |
| Local synthesis of the phosphatidylinositol-3,4-bisphosphate lipid drives focal adhesion turnover. | Dev Cell | 2022 | 35809565 | PubTator, text mining | PubMed |
| Mechanistic Effects of Baicalein on Aqueous Humor Drainage and Intraocular Pressure. | Int J Mol Sci | 2022 | 35806375 | PubTator, text mining | PubMed |
| Apoptosis signal-regulating kinase-1 regulates thrombin-induced endothelial permeability. | Vascul Pharmacol | 2022 | 35798237 | PubTator, text mining | PubMed |
| Case Report: A Chinese Family of Hypertrophic Cardiomyopathy Caused by a Novel Splicing Mutation in the FLNC Gene. | Front Genet | 2022 | 35795207 | PubTator, text mining | PubMed |
| Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy. | Front Cell Dev Biol | 2022 | 35784482 | PubTator, text mining | PubMed |
| Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury. | Inflammation | 2022 | 35779195 | PubTator, text mining | PubMed |
| SNTA1-deficient human cardiomyocytes demonstrate hypertrophic phenotype and calcium handling disorder. | Stem Cell Res Ther | 2022 | 35773684 | PubTator, text mining | PubMed |
| Hypertrophic cardiomyopathy. Proposal for a new classification. | Arch Cardiol Mex | 2022 | 35772124 | PubTator, text mining | PubMed |
| Low-Load Blood Flow Restriction Squat as Conditioning Activity Within a Contrast Training Sequence in High-Level Preadolescent Trampoline Gymnasts. | Front Physiol | 2022 | 35770193 | PubTator, text mining | PubMed |
| Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis. | Front Endocrinol (Lausanne) | 2022 | 35769086 | PubTator, text mining | PubMed |
| Transforming growth factor β1 impairs the transcriptomic response to contraction in myotubes from women with polycystic ovary syndrome. | J Physiol | 2022 | 35760527 | PubTator, text mining | PubMed |
| Modeling the human heart ex vivo-current possibilities and strive for future applications. | J Tissue Eng Regen Med | 2022 | 35748158 | PubTator, text mining | PubMed |
| Clinical characteristics and survival of children with hypertrophic cardiomyopathy in China: A multicentre retrospective cohort study. | EClinicalMedicine | 2022 | 35747179 | PubTator, text mining | PubMed |
| Exploring the Potential of Symmetric Exon Deletion to Treat Non-Ischemic Dilated Cardiomyopathy by Removing Frameshift Mutations in TTN. | Genes (Basel) | 2022 | 35741855 | PubTator, text mining | PubMed |
| Management of Pancreatic Cancer and Its Microenvironment: Potential Impact of Nano-Targeting. | Cancers (Basel) | 2022 | 35740545 | PubTator, text mining | PubMed |
| MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations. | BMC Cardiovasc Disord | 2022 | 35717150 | PubTator, text mining | PubMed |
| The potential effects of HECTD4 variants on fasting glucose and triglyceride levels in relation to prevalence of type 2 diabetes based on alcohol intake. | Arch Toxicol | 2022 | 35713687 | PubTator, text mining | PubMed |
| Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. | Circulation | 2022 | 35708014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4633/papers?page=34